This finding is consistent with transgenic studies showing overexpression of UBQLN1 can extend survival and is neuroprotective in cell and mouse models of Huntington’s and Alzheimer’s disease [1, 26, 32]. The gene discussed is UBQLN1; the disease is early-onset autosomal dominant Alzheimer disease.